Clinical Trial Update: A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis [Phase 2]

View source ↗

Summary

A Phase II study evaluating AbGn-168H for efficacy and safety in active psoriatic arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• AbGn-168H

Snippet

Sponsor: AbGenomics B.V Taiwan Branch | Conditions: Psoriatic Arthritis | Phase 2 | Status: COMPLETED